Cheng WF - Search Results

1

CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination.

Cheng WF, Hung CF, Lin KY, Ling M, Juang J, He L, Lin CT, Wu TC. Cheng WF, et al. Gene Ther. 2003 Aug;10(16):1311-20. doi: 10.1038/sj.gt.3301982. Gene Ther. 2003. PMID: 12883527

2

Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion.

Cheng WF, Hung CF, Hsu KF, Chai CY, He L, Polo JM, Slater LA, Ling M, Wu TC. Cheng WF, et al. Hum Gene Ther. 2002 Mar 1;13(4):553-68. doi: 10.1089/10430340252809847. Hum Gene Ther. 2002. PMID: 11874633

3

Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects.

Cheng WF, Hung CF, Pai SI, Hsu KF, He L, Ling M, Wu TC. Cheng WF, et al. J Biomed Sci. 2002 Nov-Dec;9(6 Pt 2):675-87. doi: 10.1159/000067285. J Biomed Sci. 2002. PMID: 12432234

4

Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes.

Hung CF, Cheng WF, He L, Ling M, Juang J, Lin CT, Wu TC. Hung CF, et al. Among authors: cheng wf. Cancer Res. 2003 May 15;63(10):2393-8. Cancer Res. 2003. PMID: 12750257

5

Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ.

Soong RS, Song L, Trieu J, Knoff J, He L, Tsai YC, Huh W, Chang YN, Cheng WF, Roden RB, Wu TC, Trimble CL, Hung CF. Soong RS, et al. Among authors: cheng wf. Clin Cancer Res. 2014 Nov 1;20(21):5456-67. doi: 10.1158/1078-0432.CCR-14-0344. Epub 2014 Jun 3. Clin Cancer Res. 2014. PMID: 24893628 Free PMC article.

6

Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen.

Cheng WF, Hung CH, Chai CY, Hsu KF, He L, Ling M, Wu TC. Cheng WF, et al. J Virol. 2001 Mar;75(5):2368-76. doi: 10.1128/JVI.75.5.2368-2376.2001. J Virol. 2001. PMID: 11160740 Free PMC article.

7

Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments.

Cheng WF, Hung CF, Hsu KF, Chai CY, He L, Ling M, Slater LA, Roden RB, Wu TC. Cheng WF, et al. Hum Gene Ther. 2001 Feb 10;12(3):235-52. doi: 10.1089/10430340150218387. Hum Gene Ther. 2001. PMID: 11177561

8

Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand.

Hung CF, Hsu KF, Cheng WF, Chai CY, He L, Ling M, Wu TC. Hung CF, et al. Among authors: cheng wf. Cancer Res. 2001 Feb 1;61(3):1080-8. Cancer Res. 2001. PMID: 11221836

9

Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen.

Hung CF, Cheng WF, Chai CY, Hsu KF, He L, Ling M, Wu TC. Hung CF, et al. Among authors: cheng wf. J Immunol. 2001 May 1;166(9):5733-40. doi: 10.4049/jimmunol.166.9.5733. J Immunol. 2001. PMID: 11313416

10

Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.

Chen CH, Wang TL, Ji H, Hung CF, Pardoll DM, Cheng WF, Ling M, Wu TC. Chen CH, et al. Among authors: cheng wf. Gene Ther. 2001 Jan;8(2):128-38. doi: 10.1038/sj.gt.3301370. Gene Ther. 2001. PMID: 11313782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page